PPHVanEck Pharmaceutical ETF
Fundamentals as of 02/28/23
-
Weighted Average Market Cap
$143.4B -
Price/Earnings Ratio
15.43
(Last 12 Months)* -
Price/Book Ratio
2.42
(Last 12 Months)*
Market Cap (% of Net Assets) as of 02/28/23
-
Large (>$5.0B)
96.73 -
Mid ($1.0 - $5.0B)
3.23 -
Small (<$1.0B)
--
3-YR Risk Measures as of 02/28/23
-
Beta vs. S&P 500 Index
0.62 -
Correlation vs. S&P 500 Index
0.79 -
Volatility (Standard Deviation)
16.34 -
Sharpe Ratio
0.63
Source: VanEck, Morningstar.
Beta is a measure of sensitivity to market movements. Correlation measures the extent of linear association between the ETF performance and the index performance. Volatility is the annualized standard deviation of the ETF's monthly returns. Sharpe ratio measures risk-adjusted return, and represents the ETF's return less the risk free rate divided by the standard deviation. See S&P 500 Index definition.5
Asset Class (% of Net Assets) as of 03/30/23
-
-
Stocks
99.75 -
Bonds
0.00 -
Other
0.00 -
Cash
0.25
Currency Exposure (%) as of 02/28/23
U.S. Dollar | 99.96 |
Other/Cash | 0.04 |
Country Weightings (%)
as of 02/28/23
Country | % of Net Assets |
---|---|
● United States | 61.99 |
● United Kingdom | 14.16 |
● Denmark | 5.79 |
● Japan | 4.84 |
● Switzerland | 4.72 |
● France | 4.52 |
● Israel | 3.95 |
● Other/Cash | 0.04 |
Sector Weightings (%)
as of 02/28/23
Sector | % of Net Assets |
---|---|
● Health Care | 94.97 |
● Consumer Staples | 4.99 |
● Other/Cash | 0.04 |